RxDoctor Payments Data

Ruwanthi Campano, MD

Otolaryngology · Palmdale, CANPI 1023018389

Payments from drug & device makers

$12,407in general payments, 2019–2025

Across 316 payments — averaging $39.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Medical Device Business Services, Inc.$2K
  • Optinose US, Inc.$1K
  • AbbVie$1K
  • Galt Pharmaceuticals, LLC$1K
  • Galderma Laboratories, L.p.$991
  • plus $4K from 18 others

What the payments were for

  • Consulting fees$1,0008%
  • Speaking & faculty fees$1501%
  • Travel & lodging$2,63221%
  • Food & beverage$8,48268%
  • Education$1421%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,407 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$462,291
Medicare patients
639
Services billed
2,445

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab29$107,352
Azelastine Hcl182$5,435
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth42$5,007
Pilocarpine Hcl62$4,795
Levocetirizine Dihydrochloride229$3,625
Fluticasone Propionate168$2,607
Fluocinolone Acetonide Oil48$2,185
Ipratropium Bromide49$1,817
Cevimeline Hcl14$1,809
Montelukast Sodium107$1,308
Hydroxyzine Hcl50$800
ValacyclovirValacyclovir Hcl11$458
Pantoprazole Sodium33$367
Ofloxacin11$329
Omeprazole28$318

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Palmdale

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →